Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001223085 | SCV001395218 | uncertain significance | Myoclonic dystonia 11 | 2025-01-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 343 of the SGCE protein (p.Arg343Trp). This variant is present in population databases (rs757796461, gnomAD 0.007%). This missense change has been observed in individual(s) with isolated cervical dystonia (PMID: 38845987). ClinVar contains an entry for this variant (Variation ID: 951224). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SGCE protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Department of Neurology, |
RCV001223085 | SCV002553220 | uncertain significance | Myoclonic dystonia 11 | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004761997 | SCV005372610 | uncertain significance | not provided | 2023-06-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously reported as pathogenic or benign in association with dystonia to our knowledge; This variant is associated with the following publications: (PMID: 27694994) |